Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. , November 15, 2023 / B3C newswire / -- Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that it has signed an exclusive global licensing agreement wit...

Related Keywords

United Kingdom , Sara Barrington , Aubrey Powell Sam , Paul Mcmanus Sam Allen , Julian Baines , Nicole Brockway , Laboratory Developed Test , Thermo Fisher , Thermo Fisher Scientific , Transplant Diagnostics , Capital Markets , Nominated Adviser , Sam Butcher , Organ Transplantation , Kidney Transplantation , Risk Assessment , Artificial Intelligence ,